117 related articles for article (PubMed ID: 9400936)
1. Prognostic value of loss of heterozygosity at BRCA2 in human breast carcinoma.
Bièche I; Noguès C; Rivoilan S; Khodja A; Latil A; Lidereau R
Br J Cancer; 1997; 76(11):1416-8. PubMed ID: 9400936
[TBL] [Abstract][Full Text] [Related]
2. Allelic loss at chromosome 13q12-q13 is associated with poor prognosis in familial and sporadic breast cancer.
van den Berg J; Johannsson O; Håkansson S; Olsson H; Borg A
Br J Cancer; 1996 Nov; 74(10):1615-9. PubMed ID: 8932343
[TBL] [Abstract][Full Text] [Related]
3. Chromosome 8p alterations in sporadic and BRCA2 999del5 linked breast cancer.
Sigbjörnsdottir BI; Ragnarsson G; Agnarsson BA; Huiping C; Barkardottir RB; Egilsson V; Ingvarsson S
J Med Genet; 2000 May; 37(5):342-7. PubMed ID: 10807692
[TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity in BRCA1 and BRCA2 markers and high-grade malignancy in breast cancer.
Silva JM; Gonzalez R; Provencio M; Dominguez G; Garcia JM; Gallego I; Palacios J; España P; Bonilla F
Breast Cancer Res Treat; 1999 Jan; 53(1):9-17. PubMed ID: 10206068
[TBL] [Abstract][Full Text] [Related]
5. Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer.
Beckmann MW; Picard F; An HX; van Roeyen CR; Dominik SI; Mosny DS; Schnürch HG; Bender HG; Niederacher D
Br J Cancer; 1996 May; 73(10):1220-6. PubMed ID: 8630282
[TBL] [Abstract][Full Text] [Related]
6. Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.
Gonzalez R; Silva JM; Dominguez G; Garcia JM; Martinez G; Vargas J; Provencio M; España P; Bonilla F
Br J Cancer; 1999 Oct; 81(3):503-9. PubMed ID: 10507777
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer after mantle irradiation for Hodgkin's disease: correlation of clinical, pathologic, and molecular features including loss of heterozygosity at BRCA1 and BRCA2.
Gaffney DK; Hemmersmeier J; Holden J; Marshall J; Smith LM; Avizonis V; Tran T; Neuhausen SL
Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):539-46. PubMed ID: 11173152
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of BRCA2 gene in sporadic breast tumours.
Bièche I; Noguès C; Lidereau R
Oncogene; 1999 Sep; 18(37):5232-8. PubMed ID: 10498873
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity at BRCA1 locus is significantly associated with aggressiveness and poor prognosis in breast cancer.
Okada S; Tokunaga E; Kitao H; Akiyoshi S; Yamashita N; Saeki H; Oki E; Morita M; Kakeji Y; Maehara Y
Ann Surg Oncol; 2012 May; 19(5):1499-507. PubMed ID: 22179631
[TBL] [Abstract][Full Text] [Related]
10. Reduced Fhit expression in sporadic and BRCA2-linked breast carcinomas.
Ingvarsson S; Agnarsson BA; Sigbjornsdottir BI; Kononen J; Kallioniemi OP; Barkardottir RB; Kovatich AJ; Schwarting R; Hauck WW; Huebner K; McCue PA
Cancer Res; 1999 Jun; 59(11):2682-9. PubMed ID: 10363992
[TBL] [Abstract][Full Text] [Related]
11. Association between loss of heterozygosity of BRCA1 and BRCA2 and morphological attributes of sporadic breast cancer.
Hanby AM; Kelsell DP; Potts HW; Gillett CE; Bishop DT; Spurr NK; Barnes DM
Int J Cancer; 2000 Oct; 88(2):204-8. PubMed ID: 11004669
[TBL] [Abstract][Full Text] [Related]
12. Allelic loss at BRCA1, BRCA2, and adjacent loci in relation to TP53 abnormality in breast cancer.
Tseng SL; Yu IC; Yue CT; Chang SF; Chang TM; Wu CW; Shen CY
Genes Chromosomes Cancer; 1997 Dec; 20(4):377-82. PubMed ID: 9408754
[TBL] [Abstract][Full Text] [Related]
13. Allelic loss at the BRCA1, BRCA2 and TP53 loci in human sporadic breast carcinoma.
Katsama A; Sourvinos G; Zachos G; Spandidos DA
Cancer Lett; 2000 Mar; 150(2):165-70. PubMed ID: 10704738
[TBL] [Abstract][Full Text] [Related]
14. Frequent loss of heterozygosity at chromosome 13q12-13 with BRCA2 markers in sporadic male breast cancer.
Prechtel D; Werenskiold AK; Prechtel K; Keller G; Höfler H
Diagn Mol Pathol; 1998 Feb; 7(1):57-62. PubMed ID: 9646036
[TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity (LOH) at p53 is correlated with LOH at BRCA1 and BRCA2 in various human malignant tumors.
Tong D; Kucera E; Schuster E; Schmutzler RK; Swoboda H; Reinthaller A; Leodolter S; Zeillinger R
Int J Cancer; 2000 Oct; 88(2):319-22. PubMed ID: 11004687
[No Abstract] [Full Text] [Related]
16. Mapping loss of heterozygosity at chromosome 13q: loss at 13q12-q13 is associated with breast tumour progression and poor prognosis.
Eiriksdottir G; Johannesdottir G; Ingvarsson S; Björnsdottir IB; Jonasson JG; Agnarsson BA; Hallgrimsson J; Gudmundsson J; Egilsson V; Sigurdsson H; Barkardottir RB
Eur J Cancer; 1998 Dec; 34(13):2076-81. PubMed ID: 10070314
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity in sporadic breast tumours at the BRCA2 locus on chromosome 13q12-q13.
Cleton-Jansen AM; Collins N; Lakhani SR; Weissenbach J; Devilee P; Cornelisse CJ; Stratton MR
Br J Cancer; 1995 Nov; 72(5):1241-4. PubMed ID: 7577475
[TBL] [Abstract][Full Text] [Related]
18. Accumulation of genetic alterations in brain metastases of sporadic breast carcinomas is associated with reduced survival after metastasis.
Hampl M; Hampl JA; Schwarz P; Frank S; Hahn M; Schackert G; Saeger HD; Schackert HK
Invasion Metastasis; 1998-1999; 18(2):81-95. PubMed ID: 10364688
[TBL] [Abstract][Full Text] [Related]
19. Replication error in human breast cancer: comparison with clinical variables and family history of cancer.
Huiping C; Johannsdottir JT; Arason A; Olafsdottir GH; Eiriksdottir G; Egilsson V; Ingvarsson S
Oncol Rep; 1999; 6(1):117-22. PubMed ID: 9864413
[TBL] [Abstract][Full Text] [Related]
20. Concomitant loss of heterozygosity at the BRCA1 and FHIT genes as a prognostic factor in sporadic breast cancer.
Silva Soares EW; de Lima Santos SC; Bueno AG; Cavalli IJ; Cavalli LR; Fouto Matias JE; de Souza Fonseca Ribeiro EM
Cancer Genet Cytogenet; 2010 May; 199(1):24-30. PubMed ID: 20417865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
